Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies

Overview of attention for article published in Nature Medicine, November 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 18 news outlets
blogs: 1 blog
twitter: 159 X users

patent: 25 patents
facebook: 3 Facebook pages
googleplus: 2 Google+ users

Citations

dimensions_citation: 199 Dimensions

Readers on

mendeley: 312 Mendeley
citeulike: 1 CiteULike

Summary News Blogs X Patents Facebook Google+ Dimensions citations

So far, Altmetric has seen 4 public wall posts from 3 users.

SJAbioscience, 19 Dec 2017

A new study finds that T cell receptor β-chain constant-targeted immunotherapy could eradicate a T cell malignancy while…

Nature Medicine, 18 Dec 2017

A new study finds that T cell receptor β-chain constant-targeted immunotherapy could eradicate a T cell malignancy while…

Mitotics, 17 Nov 2017

A new study finds that T cell receptor β-chain constant-targeted immunotherapy could eradicate a T cell malignancy while…

Nature Medicine, 17 Nov 2017

A new study finds that T cell receptor β-chain constant-targeted immunotherapy could eradicate a T cell malignancy while…